Star Combo Pharma Limited announced group revenue results for the second quarter ended 31 December 2021. The group revenue was $6.0 million for the second quarter ended 31 December 2021, compared with $7.5 million for the same period a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 AUD | +3.45% | 0.00% | +3.45% |
27/02 | Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
2023 | Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+3.45% | 13.54M | |
-.--% | 843M | |
+10.24% | 684M | |
+30.88% | 486M | |
+38.09% | 262M | |
0.00% | 135M | |
+126.09% | 64.29M |
- Stock Market
- Equities
- S66 Stock
- News Star Combo Pharma Limited
- Star Combo Pharma Limited Announces Group Revenue Results for the Second Quarter Ended 31 December 2021